Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, July 2004, p. 2544-2550, Vol. 48, No. 7
0066-4804/04/$08.00+0 DOI: 10.1128/AAC.48.7.2544-2550.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
A Chimeric Peptide Composed of a Dermaseptin Derivative and an RNA III-Inhibiting Peptide Prevents Graft-Associated Infections by Antibiotic-Resistant Staphylococci
Naomi Balaban,1* Yael Gov,1 Andrea Giacometti,2 Oscar Cirioni,2 Roberto Ghiselli,3 Federico Mocchegiani,3 Fiorenza Orlando,4 Giuseppina D'Amato,2 Vittorio Saba,3 Giorgio Scalise,2 Sabina Bernes,5 and Amram Mor5*
Department of Human Microbiology, Sackler School of Medicine, Tel Aviv University, Tel Aviv,1
Laboratory of Antimicrobial Peptides Investigation, Department of Food Engineering & Biotechnology, Technion-Israel Institute of Technology, Haifa 32000, Israel, and,5
Institute of Infectious Diseases and Public Health,2
Department of General Surgery, I.N.R.C.A., I.R.R.C.S., University of Ancona,3
Research Department, Biotechnology Center, I.N.R.C.A., I.R.R.C.S., Ancona, Italy4
Received 2 May 2003/
Returned for modification 6 October 2003/
Accepted 24 December 2003
Staphylococcal bacteria are a prevalent cause of infections associated with foreign bodies and indwelling medical devices. Bacteria are capable of escaping antibiotic treatment through encapsulation into biofilms. RNA III-inhibiting peptide (RIP) is a heptapeptide that inhibits staphylococcal biofilm formation by obstructing quorum-sensing mechanisms. K4-S4(1-13)a is a 13-residue dermaseptin derivative (DD13) believed to kill bacteria via membrane disruption. We tested each of these peptides as well as a hybrid construct, DD13-RIP, for their ability to inhibit bacterial proliferation and suppress quorum sensing in vitro and for their efficacy in preventing staphylococcal infection in a rat graft infection model with methicillin-resistant Staphylococcus aureus (MRSA) or S. epidermidis (MRSE). In vitro, proliferation assays demonstrated that RIP had no inhibitory effect, while DD13-RIP and DD13 were equally effective, and that the chimeric peptide but not DD13 was slightly more effective than RIP in inhibiting RNA III synthesis, a regulatory RNA molecule important for staphylococcal pathogenesis. In vivo, the three peptides reduced graft-associated bacterial load in a dose-dependent manner, but the hybrid peptide was most potent in totally preventing staphylococcal infections at the lowest dose. In addition, each of the peptides acted synergistically with antibiotics. The data indicate that RIP and DD13 act in synergy by attacking bacteria simultaneously by two different mechanisms. Such a chimeric peptide may be useful for coating medical devices to prevent drug-resistant staphylococcal infections.
* Corresponding author. Mailing address: Amram Mor, Laboratory of Antimicrobial Peptides Investigation, Department of Food Engineering & Biotechnology, Technion-Israel Institute of Technology, Haifa 32000, Israel. Phone: (972) 4-829-3340. Fax: (972) 4-832-0742. E-mail: amor{at}tx.technion.ac.il. Naomi Balaban, Department of Human Microbiology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. Phone: (972) 3-640-5137. E-mail: naomibalaban{at}yahoo.com.
Antimicrobial Agents and Chemotherapy, July 2004, p. 2544-2550, Vol. 48, No. 7
0066-4804/04/$08.00+0 DOI: 10.1128/AAC.48.7.2544-2550.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Balaban, N., Cirioni, O., Giacometti, A., Ghiselli, R., Braunstein, J. B., Silvestri, C., Mocchegiani, F., Saba, V., Scalise, G.
(2007). Treatment of Staphylococcus aureus Biofilm Infection by the Quorum-Sensing Inhibitor RIP. Antimicrob. Agents Chemother.
51: 2226-2229
[Abstract]
[Full Text]
-
Kwakman, P. H. S., te Velde, A. A., Vandenbroucke-Grauls, C. M. J. E., van Deventer, S. J. H., Zaat, S. A. J.
(2006). Treatment and Prevention of Staphylococcus epidermidis Experimental Biomaterial-Associated Infection by Bactericidal Peptide 2. Antimicrob. Agents Chemother.
50: 3977-3983
[Abstract]
[Full Text]
-
Rotem, S., Radzishevsky, I., Mor, A.
(2006). Physicochemical properties that enhance discriminative antibacterial activity of short dermaseptin derivatives.. Antimicrob. Agents Chemother.
50: 2666-2672
[Abstract]
[Full Text]
-
Shalev, D. E., Rotem, S., Fish, A., Mor, A.
(2006). Consequences of N-Acylation on Structure and Membrane Binding Properties of Dermaseptin Derivative K4-S4-(1-13). J. Biol. Chem.
281: 9432-9438
[Abstract]
[Full Text]
-
Korem, M., Gov, Y., Kiran, M. D., Balaban, N.
(2005). Transcriptional Profiling of Target of RNAIII-Activating Protein, a Master Regulator of Staphylococcal Virulence. Infect. Immun.
73: 6220-6228
[Abstract]
[Full Text]
-
Radzishevsky, I. S., Rotem, S., Zaknoon, F., Gaidukov, L., Dagan, A., Mor, A.
(2005). Effects of Acyl versus Aminoacyl Conjugation on the Properties of Antimicrobial Peptides. Antimicrob. Agents Chemother.
49: 2412-2420
[Abstract]
[Full Text]
-
Raffa, R. B., Iannuzzo, J. R., Levine, D. R., Saeid, K. K., Schwartz, R. C., Sucic, N. T., Terleckyj, O. D., Young, J. M.
(2005). Bacterial Communication ("Quorum Sensing") via Ligands and Receptors: A Novel Pharmacologic Target for the Design of Antibiotic Drugs. J. Pharmacol. Exp. Ther.
312: 417-423
[Abstract]
[Full Text]
Copyright © 2004 by the American Society for Microbiology. All rights reserved.